Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation

Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation

Oxidation of LDL is thought to be involved in both initiating and sustaining atherogenesis through the formation of proinflammatory lipids and the covalent modification of LDL particles. Platelet-activating factor (PAF; 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a potent phospholipid mediato...

Full description

Bibliographic Details
Main Authors:	Nicolaos Androulakis, Hervé Durand, Ewa Ninio, Demokritos C. Tsoukatos
Format:	Article
Language:	English
Published:	Elsevier 2005-09-01
Series:	Journal of Lipid Research
Subjects:	oxidized phospholipids platelet-activating factor-acetylhydrolase platelet-activating factor-transacetylase mediators of inflammation atherogenesis low density lipoprotein
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520329394

Similar Items

Modulation by flavonoids of PAF and related phospholipids in endothelial cells during oxidative stress
by: Maria Luisa Balestrieri, et al.
Published: (2003-02-01)

Increased platelet activating factor levels in chronic spontaneous urticaria predicts refractoriness to antihistamine treatment: an observational study
by: Bastsetseg Ulambayar, et al.
Published: (2019-07-01)

The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity
by: Anna I. Kakafika, et al.
Published: (2003-10-01)

Autoantibody titers against OxLDL are correlated with Achilles tendon thickness in patients with familial hypercholesterolemia
by: Sofia G. Tsouli, et al.
Published: (2006-10-01)

Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins
by: Vasilis Tsimihodimos, et al.
Published: (2003-05-01)

Class A CpG Oligonucleotide Priming Rescues Mice from Septic Shock via Activation of Platelet-Activating Factor Acetylhydrolase
by: Yoshinari Yamamoto, et al.
Published: (2017-08-01)

No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis
by: Yves Denizot, et al.
Published: (2003-01-01)

Protective role of Lipoprotein-Associated Phospholipase A2 Gene (A379V) Polymorphism against Myocardial Infarction among Egyptians
by: Ola Sharaki, et al.
Published: (2014-01-01)

Elevated plasma platelet-activating factor acetylhydrolase activity and its relationship to the presence of coronary artery disease FNx01
by: Saedziaaldin Samsamshariat, et al.
Published: (2011-01-01)

Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus
by: Takeshi Kujiraoka, et al.
Published: (2003-10-01)

To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase
by: Gopal Kedihitlu Marathe, et al.
Published: (2014-09-01)

PAF-AH catalytic subunits modulate the Wnt pathway in developing GABAergic neurons
by: Idit Livnat, et al.
Published: (2010-05-01)

Altered lipoprotein subclass distribution and PAF-AH activity in subjects with generalized aggressive periodontitis
by: Miguel L. Rufail, et al.
Published: (2005-12-01)

Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery*
by: Demokritos C. Tsoukatos, et al.
Published: (2008-10-01)

HDL inhibits the effects of oxidized phospholipids on endothelial cell gene expression via multiple mechanisms[S]
by: Benjamin Emert, et al.
Published: (2014-08-01)

Plasma Lipoprotein-Associated Phospholipase A2 Levels Correlated with the Cardio-Ankle Vascular Index in Long-Term Type 2 Diabetes Mellitus Patients
by: Kazuhiko Kotani
Published: (2016-04-01)

Aberrant Expression of PAFAH1B3 Affects Proliferation and Apoptosis in Osteosarcoma
by: Jian Fan, et al.
Published: (2021-05-01)

Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF
by: Vyala Hanumanthareddy Chaithra, et al.
Published: (2018-11-01)

Targeting Platelet in Atherosclerosis Plaque Formation: Current Knowledge and Future Perspectives
by: Lei Wang, et al.
Published: (2020-12-01)

N-linked glycosylation of macrophage-derived PAF-AH is a major determinant of enzyme association with plasma HDL
by: Alexandros D. Tselepis, et al.
Published: (2001-10-01)

Circulating biologically active oxidized phospholipids show on-going and increased oxidative stress in older male mice
by: Jinbo Liu, et al.
Published: (2013-01-01)

Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase
by: Hugo C Castro Faria Neto, et al.
Published: (2005-03-01)

Rivaroxaban Effects Illustrate the Underestimated Importance of Activated Platelets in Thrombin Generation Assessed by Calibrated Automated Thrombography
by: Stephanie Makhoul, et al.
Published: (2019-11-01)

Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia
by: Vasilis Tsimihodimos, et al.
Published: (2002-02-01)

Platelet Functions during Extracorporeal Membrane Oxygenation. Platelet–Leukocyte Aggregates Analyzed by Flow Cytometry as a Promising Tool to Monitor Platelet Activation
by: Alexandre Mansour, et al.
Published: (2020-07-01)

The emerging roles of PAF acetylhydrolase
by: Thomas M. McIntyre, et al.
Published: (2009-01-01)

Effect of safflower yellow on platelet activating factor mediated platelet activation in patients with coronary heart disease
by: Damin Huang, et al.
Published: (2012-07-01)

Evaluation of platelet activation parameters as quality markers for the stored platelets
by: Subota Vesna, et al.
Published: (2007-01-01)

Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients
by: Smaragdi Antonopoulou, et al.
Published: (2003-01-01)

The Platelet-Activating Factor Receptor’s Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine
by: Eileen Deuster, et al.
Published: (2021-09-01)

Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis
by: Stefan Blankenberg, et al.
Published: (2003-07-01)

Core aldehydes of alkyl glycerophosphocholines in atheroma induce platelet aggregation and inhibit endothelium-dependent arterial relaxation
by: Hiroshi Kamido, et al.
Published: (2002-01-01)

Aberrant expression of PAFAH1B3 associates with poor prognosis and affects proliferation and aggressiveness in hypopharyngeal squamous cell carcinoma
by: Xu J, et al.
Published: (2019-04-01)

Platelet Rich Plasma: a short overview of certain bioactive components
by: Pavlovic Voja, et al.
Published: (2016-01-01)

Investigation of Mean Platelet Volume and Platelet Count in the Blood of Patients with Migraine
by: Sefer Varol, et al.
Published: (2013-09-01)

Pharmacological characterization of prehispanolone, a PAF receptor antagonist.
Published: (1991)

Calpain Activator Dibucaine Induces Platelet Apoptosis
by: Jun Liu, et al.
Published: (2011-03-01)

Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy
by: Bernhard Jäger, et al.
Published: (2018-12-01)

Bioactive Carbohydrates and Peptides in Foods: An Overview of Sources, Downstream Processing Steps and Associated Bioactivities
by: Maria Hayes, et al.
Published: (2015-09-01)

High levels of LDL-C combined with low levels of HDL-C further increase platelet activation in hypercholesterolemic patients
by: L.W. Chan, et al.
Published: (2015-02-01)